PhD clinical research managerDiagnostica STAGOgennevilliers, Ile-de-France, France
PB0598 - Primary role in assessing the risk of severe early onset preeclampsia of phospholipid-dependent procoagulant clotting time and initiation phase of thrombin generation test
Monday, June 24, 202413:45 – 14:45 ICT
PB0600 - Tissue factor, leukemia inhibitory factor , thrombomodulin, D-Dimer, thrombin generation and procoagulant phospholipid dependent clotting time are predictive for in vitro fertilization outcome
PB1403 - Impact of determining clinical risk factors and biomarkers on the risk of cancer-associated thrombosis in newly diagnosed patients with multiple myeloma. The observational Roadmap-CAT-MM
Tuesday, June 25, 202413:45 – 14:45 ICT
PB1112 - The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration
